Cargando…

Interleukin-1 antagonists in Mevalonate Kinase Deficiency

Detalles Bibliográficos
Autores principales:	Galeotti, C, Rossi-Semerano, L, Guillaume, S, Duquesne, A, Pillet, P, Richer, O, Hachulla, E, Koné-Paut, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194730/ http://dx.doi.org/10.1186/1546-0096-9-S1-P7

Ejemplares similares

PReS-FINAL-2228: Survey of off-label ANTI-IL1 treatments in France: two years data
por: Rossi-Semerano, L, et al.
Publicado: (2013)

Survey of off-label anti-IL1 treatments in France: preliminary data
por: Rossi-Semerano, L, et al.
Publicado: (2011)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
por: Rossi-Semerano, Linda, et al.
Publicado: (2015)

Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
por: Haar, Nienke Ter, et al.
Publicado: (2014)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

Resrip: a network dedicated to children and adolescents suffering from chronic rheumatic diseases in the Ile-de-France region
por: Rossi-Semerano, Linda, et al.
Publicado: (2014)

Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency
por: Ruiz-Ortiz, E, et al.
Publicado: (2015)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
por: Jeyaratnam, J, et al.
Publicado: (2015)

PReS-FINAL-2208: Sacroilitis with propionibacterium acnes in a child
por: Galeotti, C, et al.
Publicado: (2013)

PReS-FINAL-2212: Mevalonate kinase deficiency: different faces with separate treatments
por: Gençpınar, P, et al.
Publicado: (2013)

PW03-019 – Survey of off-label ANTI-IL1 treatments in France
por: Rossi-Semerano, L, et al.
Publicado: (2013)

“Daily life of CAPS patients treated with canakinumab (Ilaris(®)) : data from the French observational study - ENVOL Study”
por: Koné-Paut, I, et al.
Publicado: (2015)

Mevalonate kinase deficiency (MKD): long-term follow-up of clinical and biological features in 40 patients
por: Florkin, B, et al.
Publicado: (2008)

PReS-FINAL-2335: Preliminary analysis of 85 patients with mevalonate kinase deficiency from the eurofever registry
por: Ter Haar, N, et al.
Publicado: (2013)

Mevalonate kinase deficiency: an early onset inflammatory bowel disease?
por: Martins, A, et al.
Publicado: (2015)

Impact of mevalonate kinase deficiency (MKD) on the quality of life in children and young adults: a national multicentre study
por: Federici, Silvia, et al.
Publicado: (2011)

International PFAPA syndrome registry: cohort of 214 patients
por: Hofer, MF, et al.
Publicado: (2008)

Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
por: Tran, TA, et al.
Publicado: (2011)

Diagnostic value of urinary mevalonic acid excretion in patietns with a clinical suspicion of mevalonate kinase deficiency (MKD)
por: Jeyaratnam, J, et al.
Publicado: (2015)

PReS-FINAL-2103: Real life management of VZV infection or reactivation in rheumatic children on biologics: the French experience
por: Guillaume-Czitrom, S, et al.
Publicado: (2013)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

The clinical spectrum of 94 French patients carrying a single mutated MEFV allele
por: Koné-Paut, I, et al.
Publicado: (2008)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)

Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016)

Is Still's Disease an Autoinflammatory Syndrome?
por: Rossi-Semerano, Linda, et al.
Publicado: (2012)

French Amyloidosis CAPS study: AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 14 cases and review of 53 cases from literature
por: Georgin-Lavialle, S, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Weekly oral alendronate in mevalonate kinase deficiency
por: Cantarini, Luca, et al.
Publicado: (2013)

Isolated neurological presentations of mevalonate kinase deficiency
por: Hoytema van Konijnenburg, Eva M. M., et al.
Publicado: (2022)

Arthrite juvénile idiopathique et Covid-19 : impact de la pandémie sur le traitement et le retour à l’école
por: Quéré, B., et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

OR11-001 - Protein misfolding in mevalonate kinase deficiency
por: Stojanov, S, et al.
Publicado: (2013)

Mevalonate kinase deficiency and IBD: shared genetic background
por: Bianco, Anna Monica, et al.
Publicado: (2014)

Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra
por: Peciuliene, Skaiste, et al.
Publicado: (2016)

Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
por: Jeyaratnam, Jerold, et al.
Publicado: (2020)

Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN
por: Mendonca, LO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e3piuddm3jns7i594b5ie4mkp2